Where can I read BMY's latest 10-K?

BMY's latest annual report, a 10-K, was filed on Feb 11, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.

When did BMY last file an 8-K?

On Jul 30, 2026 it covered results of operations; regulation fd disclosure. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Jul 30, 2026.

Are BMY insiders buying or selling?

Over the last 13 months insiders sold $2.3M in 3 sales and bought nothing on the open market; 146 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Massacesi Cristian (EVP,Chief Med Offr,Head of Dev) sold 6,249 shares on Sep 9, 2026 for $403K. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.

How many SEC filings has BMY made?

3,482 filings are on EDGAR under the registrant records that have been Bristol-Myers Squibb Company, going back to 1994; 2,275 of them are insider ownership forms (Forms 3, 4, 5 and 144).

Share this page

BMY

$59.75-1.35%

as of close, Oct 16, 2026

☾ AH $59.75 -1.35%

Bristol-Myers Squibb CompanyStock · HealthcareS&P 500 Equal Weight 0.2%S&P 500 0.2%Russell 1000 0.2%US Stock Market 0.2%Russell 3000 0.2%MSCI ACWI 0.1%MSCI World 0.1%

PeersMRNALLYMDTUNHJNJTMO

BMY SEC filings (2026)

CIK 14272 · Pharmaceutical Preparations (SIC 2834) · incorporated in DE · fiscal year ends in December

3,482 filings on EDGAR since 1994 · 36 annual, 104 quarterly, 392 current · financial statements · earnings

Latest 10-K

Feb 11, 2026

fiscal year to Dec 31, 2025

Latest 10-Q

Jul 30, 2026

quarter to Jun 30, 2026

Latest 8-K

Jul 30, 2026

Results of operations; Regulation FD disclosure

Last earnings release

Jul 30, 2026

$2.04 vs $1.59 · ▲ 2.8%

Filings on file

3,482

since 1994, 2,275 insider forms

What happened, last 12 months#

Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.

November 2025

Nov 188-K8-K · Other events
Nov 108-K8-K · Other events
Nov 38-K8-K · Other events

October 2025

Oct 30EarningsEarnings release — EPS $1.63 vs $1.48 est. (+10.1%); revenue $12.22B (+3% y/y) 7.1%
Oct 30ReportQuarterly report, Q3 2025 — revenue $12.22B (+3% y/y), net income $2.20B, EPS $1.08

Insider transactions#

What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.

Over the last 13 months insiders sold $2.3M in 3 sales and bought nothing on the open market; 146 other transactions (awards, exercises, tax withholding, gifts and plan purchases).

Date	Insider	Action	Shares	Price	Value	Held after	Filing
Sep 9, 2026Form 4	Massacesi CristianEVP,Chief Med Offr,Head of DevSold · $403K · 6,249 sh	Sold	6,249	$64.57	$403K	18,748	Form 4
Aug 25, 2026Form 4	Holzer Phil MSVP and ControllerSold · $34K · 500 sh	Sold	500	$67.50	$34K	16,862	Form 4
Apr 1, 2026Form 4	Elkins David VEVP, Chief Financial OfficerSold · $1.9M · 30,000 sh	Sold	30,000	$61.60–$62.05	$1.9M	159,248	Form 4

Awards, exercises, withholding and plan purchases · 146 transactions

Date	Insider	Action	Shares	Price	Value	Held after	Filing
Oct 2, 2026Form 4	Gallman CariEVP, General CounselTax withholding · $143K · 2,332 sh	Tax withholding	2,332	$61.15	$143K	15,876	Form 4
Oct 2, 2026Form 4	Gallman CariEVP, General CounselExercise or conversion · $0 · 4,559 sh	Exercise or conversion	4,559	$0.00	$0	18,208	Form 4
Oct 2, 2026Form 4	Gallman CariEVP, General CounselExercise or conversion · Restricted Stock Units · $0 · 4,559 sh	Exercise or conversion· Restricted Stock Units	4,559	$0.00	$0	0	Form 4
Sep 30, 2026Form 4	Samuels Theodore R. IIDirectorAward · Deferred Share Units · $51K · 821.314 sh	Award· Deferred Share Units	821.314	$62.40	$51K	71,859.041	Form 4
Sep 30, 2026Form 4	Rice Derica WDirectorAward · Deferred Share Units · $39K · 620.994 sh	Award· Deferred Share Units	620.994	$62.40	$39K	42,084.867	Form 4
Sep 30, 2026Form 4	YALE PHYLLIS RDirectorAward · Deferred Share Units · $35K · 560.897 sh	Award· Deferred Share Units	560.897	$62.40	$35K	45,980.077	Form 4
Sep 30, 2026Form 4	Arduini Peter JDirectorAward · Deferred Share Units · $35K · 560.897 sh	Award· Deferred Share Units	560.897	$62.40	$35K	74,077.176	Form 4
Sep 30, 2026Form 4	McMullen Michael R.DirectorAward · Deferred Share Units · $35K · 560.897 sh	Award· Deferred Share Units	560.897	$62.40	$35K	17,050.601	Form 4
Sep 1, 2026Form 4	Short Bartie WendyEVP, Corporate AffairsExercise or conversion · $83K · 1,236 sh	Exercise or conversion	1,236	$66.92	$83K	13,317	Form 4
Sep 1, 2026Form 4	Short Bartie WendyEVP, Corporate AffairsTax withholding · $42K · 633 sh	Tax withholding	633	$66.92	$42K	12,684	Form 4
Sep 1, 2026Form 4	Short Bartie WendyEVP, Corporate AffairsExercise or conversion · Restricted Stock Units · $0 · 1,236 sh	Exercise or conversion· Restricted Stock Units	1,236	$0.00	$0	0	Form 4
Aug 1, 2026Form 4	Massacesi CristianEVP,Chief Med Offr,Head of DevTax withholding · $1.7M · 26,175 sh	Tax withholding	26,175	$65.31	$1.7M	24,997	Form 4
Aug 1, 2026Form 4	Gallman CariEVP, General CounselTax withholding · $35K · 543 sh	Tax withholding	543	$65.31	$35K	13,649	Form 4
Aug 1, 2026Form 4	Massacesi CristianEVP,Chief Med Offr,Head of DevExercise or conversion · $0 · 51,172 sh	Exercise or conversion	51,172	$0.00	$0	51,172	Form 4
Aug 1, 2026Form 4	Massacesi CristianEVP,Chief Med Offr,Head of DevExercise or conversion · Restricted Stock Units · $0 · 51,172 sh	Exercise or conversion· Restricted Stock Units	51,172	$0.00	$0	153,519	Form 4
Aug 1, 2026Form 4	Gallman CariEVP, General CounselExercise or conversion · $0 · 1,061 sh	Exercise or conversion	1,061	$0.00	$0	14,192	Form 4
Aug 1, 2026Form 4	Gallman CariEVP, General CounselExercise or conversion · Restricted Stock Units · $0 · 1,061 sh	Exercise or conversion· Restricted Stock Units	1,061	$0.00	$0	0	Form 4
Jun 30, 2026Form 4	Samuels Theodore R. IIDirectorAward · Deferred Share Units · $51K · 889.448 sh	Award· Deferred Share Units	889.448	$57.62	$51K	70,360.664	Form 4
Jun 30, 2026Form 4	Rice Derica WDirectorAward · Deferred Share Units · $39K · 672.51 sh	Award· Deferred Share Units	672.51	$57.62	$39K	41,068.681	Form 4
Jun 30, 2026Form 4	YALE PHYLLIS RDirectorAward · Deferred Share Units · $35K · 607.428 sh	Award· Deferred Share Units	607.428	$57.62	$35K	44,986.288	Form 4
Jun 30, 2026Form 4	Arduini Peter JDirectorAward · Deferred Share Units · $35K · 607.428 sh	Award· Deferred Share Units	607.428	$57.62	$35K	72,815.595	Form 4
Jun 30, 2026Form 4	McMullen Michael R.DirectorAward · Deferred Share Units · $35K · 607.428 sh	Award· Deferred Share Units	607.428	$57.62	$35K	16,332.54	Form 4
Jun 15, 2026Form 4	Haller Julia ADirectorExercise or conversion · $1.1M · 20,460 sh	Exercise or conversion	20,460	$53.76	$1.1M	34,079	Form 4
Jun 15, 2026Form 4	Haller Julia ADirectorExercise or conversion · Option (right to buy) · $0 · 20,460 sh	Exercise or conversion· Option (right to buy)	20,460	$0.00	$0	0	Form 4
Jun 3, 2026Form 4	Short Bartie WendyEVP, Corporate AffairsTax withholding · $212K · 3,876 sh	Tax withholding	3,876	$54.72	$212K	12,081	Form 4
Jun 3, 2026Form 4	Short Bartie WendyEVP, Corporate AffairsExercise or conversion · $0 · 8,040 sh	Exercise or conversion	8,040	$0.00	$0	15,957	Form 4
Jun 3, 2026Form 4	Short Bartie WendyEVP, Corporate AffairsExercise or conversion · Restricted Stock Units · $0 · 8,040 sh	Exercise or conversion· Restricted Stock Units	8,040	$0.00	$0	8,040	Form 4
May 1, 2026Form 4	Lenkowsky AdamEVP, Chief Commercial OfficerTax withholding · $35K · 599 sh	Tax withholding	599	$58.22	$35K	19,706	Form 4
May 1, 2026Form 4	Lenkowsky AdamEVP, Chief Commercial OfficerExercise or conversion · $0 · 1,373 sh	Exercise or conversion	1,373	$0.00	$0	20,508	Form 4
May 1, 2026Form 4	Lenkowsky AdamEVP, Chief Commercial OfficerExercise or conversion · Market Share Units · $0 · 1,373 sh	Exercise or conversion· Market Share Units	1,373	$0.00	$0	1,375	Form 4
May 1, 2026Form 4	Lenkowsky AdamEVP, Chief Commercial OfficerOther · $0 · 203 sh	Other	203	$0.00	$0	20,305	Form 4
Apr 1, 2026Form 4	Shanahan KarinEVP, Chief Supply Chain & OpsTax withholding · $104K · 1,692 sh	Tax withholding	1,692	$61.73	$104K	25,888	Form 4
Apr 1, 2026Form 4	Shanahan KarinEVP, Chief Supply Chain & OpsExercise or conversion · $0 · 3,307 sh	Exercise or conversion	3,307	$0.00	$0	27,580	Form 4
Apr 1, 2026Form 4	Shanahan KarinEVP, Chief Supply Chain & OpsExercise or conversion · Restricted Stock Units · $0 · 3,307 sh	Exercise or conversion· Restricted Stock Units	3,307	$0.00	$0	0	Form 4
Mar 31, 2026Form 4	Samuels Theodore R. IIDirectorAward · Deferred Share Units · $51K · 845.012 sh	Award· Deferred Share Units	845.012	$60.65	$51K	68,727.516	Form 4
Mar 31, 2026Form 4	Rice Derica WDirectorAward · Deferred Share Units · $39K · 638.912 sh	Award· Deferred Share Units	638.912	$60.65	$39K	39,963.721	Form 4
Mar 31, 2026Form 4	YALE PHYLLIS RDirectorAward · Deferred Share Units · $35K · 577.082 sh	Award· Deferred Share Units	577.082	$60.65	$35K	43,903.777	Form 4
Mar 31, 2026Form 4	Arduini Peter JDirectorAward · Deferred Share Units · $35K · 577.082 sh	Award· Deferred Share Units	577.082	$60.65	$35K	71,435.166	Form 4
Mar 31, 2026Form 4	McMullen Michael R.DirectorAward · Deferred Share Units · $35K · 577.082 sh	Award· Deferred Share Units	577.082	$60.65	$35K	15,556.771	Form 4
Mar 10, 2026Form 4	BOERNER CHRISTOPHER S.Chief Executive Officer · DirectorTax withholding · $1.3M · 21,229 sh	Tax withholding	21,229	$60.13	$1.3M	21,451	Form 4
Mar 10, 2026Form 4	Elkins David VEVP, Chief Financial OfficerTax withholding · $969K · 16,114 sh	Tax withholding	16,114	$60.13	$969K	189,248	Form 4
Mar 10, 2026Form 4	Shanahan KarinEVP, Chief Supply Chain & OpsTax withholding · $467K · 7,760 sh	Tax withholding	7,760	$60.13	$467K	24,273	Form 4
Mar 10, 2026Form 4	Lenkowsky AdamEVP, Chief Commercial OfficerTax withholding · $422K · 7,015 sh	Tax withholding	7,015	$60.13	$422K	19,135	Form 4
Mar 10, 2026Form 4	Meyers Gregory ScottEVP, Chief Digital & Tech Off.Tax withholding · $396K · 6,582 sh	Tax withholding	6,582	$60.13	$396K	30,361	Form 4
Mar 10, 2026Form 4	Plenge Robert MEVP, Chief Research OfficerTax withholding · $273K · 4,535 sh	Tax withholding	4,535	$60.13	$273K	21,528	Form 4
Mar 10, 2026Form 4	Gallman CariEVP, General CounselTax withholding · $130K · 2,165 sh	Tax withholding	2,165	$60.13	$130K	13,131	Form 4
Mar 10, 2026Form 4	Poole Ahn AmandaEVP, Chief People OfficerTax withholding · $120K · 1,992 sh	Tax withholding	1,992	$60.13	$120K	7,094	Form 4
Mar 10, 2026Form 4	Hoch LynellePresident, Cell Therapy Org.Tax withholding · $84K · 1,391 sh	Tax withholding	1,391	$60.13	$84K	8,210	Form 4
Mar 10, 2026Form 4	Holzer Phil MSVP and ControllerTax withholding · $82K · 1,358 sh	Tax withholding	1,358	$60.13	$82K	17,362	Form 4
Mar 10, 2026Form 4	Short Bartie WendyEVP, Corporate AffairsTax withholding · $77K · 1,275 sh	Tax withholding	1,275	$60.13	$77K	7,917	Form 4
Mar 10, 2026Form 4	BOERNER CHRISTOPHER S.Chief Executive Officer · DirectorAward · $0 · 156,735 sh	Award	156,735	$0.00	$0	156,735	Form 4
Mar 10, 2026Form 4	BOERNER CHRISTOPHER S.Chief Executive Officer · DirectorAward · Market Share Units · $0 · 104,490 sh	Award· Market Share Units	104,490	$0.00	$0	104,490	Form 4
Mar 10, 2026Form 4	BOERNER CHRISTOPHER S.Chief Executive Officer · DirectorExercise or conversion · $0 · 71,537 sh	Exercise or conversion	71,537	$0.00	$0	34,817	Form 4
Mar 10, 2026Form 4	Elkins David VEVP, Chief Financial OfficerExercise or conversion · $0 · 62,982 sh	Exercise or conversion	62,982	$0.00	$0	222,773	Form 4
Mar 10, 2026Form 4	BOERNER CHRISTOPHER S.Chief Executive Officer · DirectorExercise or conversion · $0 · 58,186 sh	Exercise or conversion	58,186	$0.00	$0	0	Form 4
Mar 10, 2026Form 4	Elkins David VEVP, Chief Financial OfficerAward · $0 · 52,898 sh	Award	52,898	$0.00	$0	52,898	Form 4
Mar 10, 2026Form 4	Lenkowsky AdamEVP, Chief Commercial OfficerAward · $0 · 48,980 sh	Award	48,980	$0.00	$0	48,980	Form 4
Mar 10, 2026Form 4	Elkins David VEVP, Chief Financial OfficerExercise or conversion · $0 · 47,424 sh	Exercise or conversion	47,424	$0.00	$0	0	Form 4
Mar 10, 2026Form 4	Meyers Gregory ScottEVP, Chief Digital & Tech Off.Award · $0 · 39,184 sh	Award	39,184	$0.00	$0	39,184	Form 4
Mar 10, 2026Form 4	Gallman CariEVP, General CounselAward · $0 · 39,184 sh	Award	39,184	$0.00	$0	39,184	Form 4
Mar 10, 2026Form 4	Massacesi CristianEVP,Chief Med Offr,Head of DevAward · $0 · 39,184 sh	Award	39,184	$0.00	$0	39,184	Form 4
Mar 10, 2026Form 4	Elkins David VEVP, Chief Financial OfficerAward · Market Share Units · $0 · 35,265 sh	Award· Market Share Units	35,265	$0.00	$0	35,265	Form 4
Mar 10, 2026Form 4	Lenkowsky AdamEVP, Chief Commercial OfficerAward · Market Share Units · $0 · 32,653 sh	Award· Market Share Units	32,653	$0.00	$0	32,653	Form 4
Mar 10, 2026Form 4	Shanahan KarinEVP, Chief Supply Chain & OpsAward · $0 · 31,837 sh	Award	31,837	$0.00	$0	31,837	Form 4
Mar 10, 2026Form 4	BOERNER CHRISTOPHER S.Chief Executive Officer · DirectorOther · $0 · 30,039 sh	Other	30,039	$0.00	$0	26,083	Form 4
Mar 10, 2026Form 4	Plenge Robert MEVP, Chief Research OfficerAward · $0 · 26,939 sh	Award	26,939	$0.00	$0	26,939	Form 4
Mar 10, 2026Form 4	Meyers Gregory ScottEVP, Chief Digital & Tech Off.Award · Market Share Units · $0 · 26,122 sh	Award· Market Share Units	26,122	$0.00	$0	26,122	Form 4
Mar 10, 2026Form 4	Gallman CariEVP, General CounselAward · Market Share Units · $0 · 26,122 sh	Award· Market Share Units	26,122	$0.00	$0	26,122	Form 4
Mar 10, 2026Form 4	Massacesi CristianEVP,Chief Med Offr,Head of DevAward · Market Share Units · $0 · 26,122 sh	Award· Market Share Units	26,122	$0.00	$0	26,122	Form 4
Mar 10, 2026Form 4	Meyers Gregory ScottEVP, Chief Digital & Tech Off.Exercise or conversion · $0 · 25,892 sh	Exercise or conversion	25,892	$0.00	$0	44,330	Form 4
Mar 10, 2026Form 4	Shanahan KarinEVP, Chief Supply Chain & OpsExercise or conversion · $0 · 25,501 sh	Exercise or conversion	25,501	$0.00	$0	39,120	Form 4
Mar 10, 2026Form 4	Elkins David VEVP, Chief Financial OfficerOther · $0 · 24,999 sh	Other	24,999	$0.00	$0	199,488	Form 4
Mar 10, 2026Form 4	Lenkowsky AdamEVP, Chief Commercial OfficerExercise or conversion · $0 · 24,071 sh	Exercise or conversion	24,071	$0.00	$0	25,327	Form 4
Mar 10, 2026Form 4	Poole Ahn AmandaEVP, Chief People OfficerAward · $0 · 23,020 sh	Award	23,020	$0.00	$0	23,020	Form 4
Mar 10, 2026Form 4	Shanahan KarinEVP, Chief Supply Chain & OpsAward · Market Share Units · $0 · 21,224 sh	Award· Market Share Units	21,224	$0.00	$0	21,224	Form 4
Mar 10, 2026Form 4	Lenkowsky AdamEVP, Chief Commercial OfficerExercise or conversion · $0 · 20,243 sh	Exercise or conversion	20,243	$0.00	$0	0	Form 4
Mar 10, 2026Form 4	Meyers Gregory ScottEVP, Chief Digital & Tech Off.Exercise or conversion · $0 · 19,760 sh	Exercise or conversion	19,760	$0.00	$0	0	Form 4
Mar 10, 2026Form 4	Shanahan KarinEVP, Chief Supply Chain & OpsExercise or conversion · $0 · 19,760 sh	Exercise or conversion	19,760	$0.00	$0	0	Form 4
Mar 10, 2026Form 4	Plenge Robert MEVP, Chief Research OfficerAward · Market Share Units · $0 · 17,959 sh	Award· Market Share Units	17,959	$0.00	$0	17,959	Form 4
Mar 10, 2026Form 4	Plenge Robert MEVP, Chief Research OfficerExercise or conversion · $0 · 17,501 sh	Exercise or conversion	17,501	$0.00	$0	31,600	Form 4
Mar 10, 2026Form 4	Hickey BenjaminPresident, RayzeBio Org.Award · $0 · 17,143 sh	Award	17,143	$0.00	$0	17,143	Form 4
Mar 10, 2026Form 4	Elkins David VEVP, Chief Financial OfficerExercise or conversion · Market Share Units · $0 · 15,558 sh	Exercise or conversion· Market Share Units	15,558	$0.00	$0	7,904	Form 4
Mar 10, 2026Form 4	Poole Ahn AmandaEVP, Chief People OfficerAward · Market Share Units · $0 · 15,347 sh	Award· Market Share Units	15,347	$0.00	$0	15,347	Form 4
Mar 10, 2026Form 4	Plenge Robert MEVP, Chief Research OfficerExercise or conversion · $0 · 14,052 sh	Exercise or conversion	14,052	$0.00	$0	0	Form 4
Mar 10, 2026Form 4	BOERNER CHRISTOPHER S.Chief Executive Officer · DirectorExercise or conversion · Market Share Units · $0 · 13,351 sh	Exercise or conversion· Market Share Units	13,351	$0.00	$0	6,733	Form 4
Mar 10, 2026Form 4	Shibutani Hiroshi ChrisEVP, Chief Strategy OfficerAward · $0 · 11,755 sh	Award	11,755	$0.00	$0	11,755	Form 4
Mar 10, 2026Form 4	Hickey BenjaminPresident, RayzeBio Org.Award · Market Share Units · $0 · 11,429 sh	Award· Market Share Units	11,429	$0.00	$0	11,429	Form 4
Mar 10, 2026Form 4	Meyers Gregory ScottEVP, Chief Digital & Tech Off.Other · $0 · 10,377 sh	Other	10,377	$0.00	$0	34,628	Form 4
Mar 10, 2026Form 4	Lenkowsky AdamEVP, Chief Commercial OfficerOther · $0 · 10,360 sh	Other	10,360	$0.00	$0	21,281	Form 4
Mar 10, 2026Form 4	Shanahan KarinEVP, Chief Supply Chain & OpsOther · $0 · 10,333 sh	Other	10,333	$0.00	$0	29,418	Form 4
Mar 10, 2026Form 4	Hoch LynellePresident, Cell Therapy Org.Award · $0 · 9,796 sh	Award	9,796	$0.00	$0	9,796	Form 4
Mar 10, 2026Form 4	Short Bartie WendyEVP, Corporate AffairsAward · $0 · 9,796 sh	Award	9,796	$0.00	$0	9,796	Form 4
Mar 10, 2026Form 4	Hoch LynellePresident, Cell Therapy Org.Exercise or conversion · $0 · 8,192 sh	Exercise or conversion	8,192	$0.00	$0	12,217	Form 4
Mar 10, 2026Form 4	Shibutani Hiroshi ChrisEVP, Chief Strategy OfficerAward · Market Share Units · $0 · 7,837 sh	Award· Market Share Units	7,837	$0.00	$0	7,837	Form 4
Mar 10, 2026Form 4	Holzer Phil MSVP and ControllerAward · $0 · 7,547 sh	Award	7,547	$0.00	$0	7,547	Form 4
Mar 10, 2026Form 4	Plenge Robert MEVP, Chief Research OfficerOther · $0 · 7,277 sh	Other	7,277	$0.00	$0	24,700	Form 4
Mar 10, 2026Form 4	Gallman CariEVP, General CounselExercise or conversion · $0 · 6,980 sh	Exercise or conversion	6,980	$0.00	$0	17,039	Form 4
Mar 10, 2026Form 4	Hoch LynellePresident, Cell Therapy Org.Award · Market Share Units · $0 · 6,531 sh	Award· Market Share Units	6,531	$0.00	$0	6,531	Form 4
Mar 10, 2026Form 4	Short Bartie WendyEVP, Corporate AffairsAward · Market Share Units · $0 · 6,531 sh	Award· Market Share Units	6,531	$0.00	$0	6,531	Form 4
Mar 10, 2026Form 4	Poole Ahn AmandaEVP, Chief People OfficerExercise or conversion · $0 · 6,436 sh	Exercise or conversion	6,436	$0.00	$0	10,718	Form 4
Mar 10, 2026Form 4	Hoch LynellePresident, Cell Therapy Org.Exercise or conversion · $0 · 6,304 sh	Exercise or conversion	6,304	$0.00	$0	0	Form 4
Mar 10, 2026Form 4	Holzer Phil MSVP and ControllerExercise or conversion · $0 · 6,191 sh	Exercise or conversion	6,191	$0.00	$0	20,475	Form 4
Mar 10, 2026Form 4	Meyers Gregory ScottEVP, Chief Digital & Tech Off.Exercise or conversion · Market Share Units · $0 · 6,132 sh	Exercise or conversion· Market Share Units	6,132	$0.00	$0	3,294	Form 4
Mar 10, 2026Form 4	Short Bartie WendyEVP, Corporate AffairsExercise or conversion · $0 · 5,883 sh	Exercise or conversion	5,883	$0.00	$0	10,952	Form 4
Mar 10, 2026Form 4	Shanahan KarinEVP, Chief Supply Chain & OpsExercise or conversion · Market Share Units · $0 · 5,741 sh	Exercise or conversion· Market Share Units	5,741	$0.00	$0	3,294	Form 4
Mar 10, 2026Form 4	Gallman CariEVP, General CounselExercise or conversion · $0 · 5,201 sh	Exercise or conversion	5,201	$0.00	$0	0	Form 4
Mar 10, 2026Form 4	Holzer Phil MSVP and ControllerAward · Market Share Units · $0 · 5,031 sh	Award· Market Share Units	5,031	$0.00	$0	5,031	Form 4
Mar 10, 2026Form 4	Poole Ahn AmandaEVP, Chief People OfficerExercise or conversion · $0 · 4,822 sh	Exercise or conversion	4,822	$0.00	$0	0	Form 4
Mar 10, 2026Form 4	Holzer Phil MSVP and ControllerExercise or conversion · $0 · 4,612 sh	Exercise or conversion	4,612	$0.00	$0	0	Form 4
Mar 10, 2026Form 4	Short Bartie WendyEVP, Corporate AffairsExercise or conversion · $0 · 4,495 sh	Exercise or conversion	4,495	$0.00	$0	0	Form 4
Mar 10, 2026Form 4	Lenkowsky AdamEVP, Chief Commercial OfficerExercise or conversion · Market Share Units · $0 · 3,828 sh	Exercise or conversion· Market Share Units	3,828	$0.00	$0	2,001	Form 4
Mar 10, 2026Form 4	Plenge Robert MEVP, Chief Research OfficerExercise or conversion · Market Share Units · $0 · 3,449 sh	Exercise or conversion· Market Share Units	3,449	$0.00	$0	2,342	Form 4
Mar 10, 2026Form 4	Hoch LynellePresident, Cell Therapy Org.Other · $0 · 3,302 sh	Other	3,302	$0.00	$0	9,122	Form 4
Mar 10, 2026Form 4	Gallman CariEVP, General CounselOther · $0 · 2,750 sh	Other	2,750	$0.00	$0	14,485	Form 4
Mar 10, 2026Form 4	Poole Ahn AmandaEVP, Chief People OfficerOther · $0 · 2,546 sh	Other	2,546	$0.00	$0	8,350	Form 4
Mar 10, 2026Form 4	Holzer Phil MSVP and ControllerOther · $0 · 2,438 sh	Other	2,438	$0.00	$0	18,211	Form 4
Mar 10, 2026Form 4	Short Bartie WendyEVP, Corporate AffairsOther · $0 · 2,360 sh	Other	2,360	$0.00	$0	8,745	Form 4
Mar 10, 2026Form 4	Hoch LynellePresident, Cell Therapy Org.Exercise or conversion · Market Share Units · $0 · 1,888 sh	Exercise or conversion· Market Share Units	1,888	$0.00	$0	1,052	Form 4
Mar 10, 2026Form 4	Gallman CariEVP, General CounselExercise or conversion · Market Share Units · $0 · 1,779 sh	Exercise or conversion· Market Share Units	1,779	$0.00	$0	867	Form 4
Mar 10, 2026Form 4	Poole Ahn AmandaEVP, Chief People OfficerExercise or conversion · Market Share Units · $0 · 1,614 sh	Exercise or conversion· Market Share Units	1,614	$0.00	$0	805	Form 4
Mar 10, 2026Form 4	Holzer Phil MSVP and ControllerExercise or conversion · Market Share Units · $0 · 1,579 sh	Exercise or conversion· Market Share Units	1,579	$0.00	$0	771	Form 4
Mar 10, 2026Form 4	Short Bartie WendyEVP, Corporate AffairsExercise or conversion · Market Share Units · $0 · 1,388 sh	Exercise or conversion· Market Share Units	1,388	$0.00	$0	750	Form 4
Feb 27, 2026Form 4	Hickey BenjaminPresident, RayzeBio Org.Tax withholding · $104K · 1,672 sh	Tax withholding	1,672	$62.37	$104K	16,672	Form 4
Feb 27, 2026Form 4	Hickey BenjaminPresident, RayzeBio Org.Exercise or conversion · $0 · 3,286 sh	Exercise or conversion	3,286	$0.00	$0	18,344	Form 4
Feb 27, 2026Form 4	Hickey BenjaminPresident, RayzeBio Org.Exercise or conversion · Restricted Stock Units · $0 · 3,286 sh	Exercise or conversion· Restricted Stock Units	3,286	$0.00	$0	3,286	Form 4
Feb 1, 2026Form 4	YALE PHYLLIS RDirectorAward · Deferred Share Units · $220K · 3,996.367 sh	Award· Deferred Share Units	3,996.367	$55.05	$220K	43,326.695	Form 4
Feb 1, 2026Form 4	Arduini Peter JDirectorAward · Deferred Share Units · $220K · 3,996.367 sh	Award· Deferred Share Units	3,996.367	$55.05	$220K	70,858.084	Form 4
Feb 1, 2026Form 4	Rice Derica WDirectorAward · Deferred Share Units · $220K · 3,996.367 sh	Award· Deferred Share Units	3,996.367	$55.05	$220K	39,324.809	Form 4
Feb 1, 2026Form 4	Price Paula ADirectorAward · Deferred Share Units · $220K · 3,996.367 sh	Award· Deferred Share Units	3,996.367	$55.05	$220K	25,498.163	Form 4
Feb 1, 2026Form 4	McMullen Michael R.DirectorAward · Deferred Share Units · $220K · 3,996.367 sh	Award· Deferred Share Units	3,996.367	$55.05	$220K	14,979.689	Form 4
Feb 1, 2026Form 4	Haller Julia ADirectorAward · Deferred Share Units · $220K · 3,996.367 sh	Award· Deferred Share Units	3,996.367	$55.05	$220K	37,903.154	Form 4
Feb 1, 2026Form 4	Samuels Theodore R. IIDirectorAward · Deferred Share Units · $220K · 3,996.367 sh	Award· Deferred Share Units	3,996.367	$55.05	$220K	67,882.504	Form 4
Feb 1, 2026Form 4	Vousden Karen HDirectorAward · Deferred Share Units · $220K · 3,996.367 sh	Award· Deferred Share Units	3,996.367	$55.05	$220K	41,069.315	Form 4
Feb 1, 2026Form 4	Hidalgo Medina ManuelDirectorAward · Deferred Share Units · $220K · 3,996.367 sh	Award· Deferred Share Units	3,996.367	$55.05	$220K	22,763.938	Form 4
Feb 1, 2026Form 4	Bhatt DeepakDirectorAward · Deferred Share Units · $220K · 3,996.367 sh	Award· Deferred Share Units	3,996.367	$55.05	$220K	19,241.818	Form 4
Feb 1, 2026Form 4	Hickey BenjaminPresident, RayzeBio Org.Tax withholding · $210K · 3,810 sh	Tax withholding	3,810	$55.05	$210K	15,058	Form 4
Feb 1, 2026Form 4	Meyers Gregory ScottEVP, Chief Digital & Tech Off.Tax withholding · $46K · 833 sh	Tax withholding	833	$55.05	$46K	21,428	Form 4
Feb 1, 2026Form 4	Hickey BenjaminPresident, RayzeBio Org.Exercise or conversion · $0 · 10,079 sh	Exercise or conversion	10,079	$0.00	$0	18,868	Form 4
Feb 1, 2026Form 4	Hickey BenjaminPresident, RayzeBio Org.Exercise or conversion · Restricted Stock Units · $0 · 10,079 sh	Exercise or conversion· Restricted Stock Units	10,079	$0.00	$0	10,079	Form 4
Feb 1, 2026Form 4	Meyers Gregory ScottEVP, Chief Digital & Tech Off.Exercise or conversion · $0 · 2,543 sh	Exercise or conversion	2,543	$0.00	$0	22,261	Form 4
Feb 1, 2026Form 4	Meyers Gregory ScottEVP, Chief Digital & Tech Off.Exercise or conversion · Restricted Stock Units · $0 · 2,543 sh	Exercise or conversion· Restricted Stock Units	2,543	$0.00	$0	0	Form 4
Dec 31, 2025Form 4	Samuels Theodore R. IIDirectorAward · Deferred Share Units · $0 · 926.956 sh	Award· Deferred Share Units	926.956	$0.00	$0	63,174.032	Form 4
Dec 31, 2025Form 4	Rice Derica WDirectorAward · Deferred Share Units · $0 · 695.217 sh	Award· Deferred Share Units	695.217	$0.00	$0	34,934.653	Form 4
Dec 31, 2025Form 4	YALE PHYLLIS RDirectorAward · Deferred Share Units · $0 · 648.869 sh	Award· Deferred Share Units	648.869	$0.00	$0	38,891.933	Form 4
Dec 31, 2025Form 4	McMullen Michael R.DirectorAward · Deferred Share Units · $0 · 648.869 sh	Award· Deferred Share Units	648.869	$0.00	$0	10,860.897	Form 4
Dec 31, 2025Form 4	Arduini Peter JDirectorAward · Deferred Share Units · $0 · 625.695 sh	Award· Deferred Share Units	625.695	$0.00	$0	66,116.446	Form 4

Reports and proxy statements#

Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.

2026 · 12 filings

Filed	Form	What it is	Period
Jul 30, 202610-Q	10-Q	Quarterly report, Q2 2026 — revenue $12.97B (+6% y/y), net income $3.32B, EPS $1.62	Jun 30, 2026
Jul 30, 20268-K	8-K	Earnings release — EPS $2.04 vs $1.59 est. (+28.3%); revenue $12.97B (+6% y/y) 2.8%	Jul 30, 2026
May 8, 20268-K	8-K	Shareholder vote results	May 5, 2026
Apr 30, 202610-Q	10-Q	Quarterly report, Q1 2026 — revenue $11.49B (+3% y/y), net income $2.68B, EPS $1.31	Mar 31, 2026
Apr 30, 20268-K	8-K	Earnings release — EPS $1.58 vs $1.44 est. (+9.7%); revenue $11.49B (+3% y/y) 5.2%	Apr 30, 2026
Apr 17, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Mar 25, 2026ARS	ARS	Annual report to shareholders	Dec 31, 2025
Mar 25, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Mar 25, 2026DEF 14A	DEF 14A	Proxy statement	May 5, 2026
Feb 11, 202610-K	10-K	Annual report, FY2025 — revenue $48.19B (−0% y/y), net income $7.05B, EPS $3.46	Dec 31, 2025
Feb 5, 20268-K	8-K	Earnings release — EPS $1.26 vs $1.15 est. (+9.6%); revenue $12.50B (+1% y/y) 3.3%	Feb 5, 2026
Jan 12, 20268-K	8-K	Regulation FD disclosure	Jan 12, 2026

2025 · 19 filings

Filed	Form	What it is	Period
Nov 18, 20258-K	8-K	Other events	Nov 17, 2025
Nov 10, 20258-K	8-K	Other events	Oct 31, 2025
Nov 3, 20258-K	8-K	Other events	Nov 3, 2025
Oct 30, 202510-Q	10-Q	Quarterly report, Q3 2025 — revenue $12.22B (+3% y/y), net income $2.20B, EPS $1.08	Sep 30, 2025
Oct 30, 20258-K	8-K	Earnings release — EPS $1.63 vs $1.48 est. (+10.1%); revenue $12.22B (+3% y/y) 7.1%	Oct 30, 2025
Jul 31, 202510-Q	10-Q	Quarterly report, Q2 2025 — revenue $12.27B (+1% y/y), net income $1.31B, EPS $0.64	Jun 30, 2025
Jul 31, 20258-K	8-K	Results of operations; Regulation FD disclosure	Jul 31, 2025
Jul 25, 20258-K	8-K	Directors or officers; compensation	Jul 21, 2025
May 7, 20258-K	8-K	Shareholder vote results	May 6, 2025
Apr 24, 202510-Q	10-Q	Quarterly report, Q1 2025 — revenue $11.20B (−6% y/y), net income $2.46B, EPS $1.20	Mar 31, 2025
Apr 24, 20258-K	8-K	Results of operations; Regulation FD disclosure	Apr 24, 2025
Apr 15, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Mar 26, 2025ARS	ARS	Annual report to shareholders	Dec 31, 2024
Mar 26, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Mar 26, 2025DEF 14A	DEF 14A	Proxy statement	Dec 31, 2024
Feb 18, 20258-K	8-K	Directors or officers; compensation	Feb 14, 2025
Feb 12, 202510-K	10-K	Annual report, FY2024 — revenue $48.30B (+7% y/y), net income −$8.95B, EPS −$4.41	Dec 31, 2024
Feb 6, 20258-K	8-K	Results of operations; Regulation FD disclosure	Feb 6, 2025
Jan 13, 20258-K	8-K	Regulation FD disclosure	Jan 13, 2025

2024 · 21 filings

Filed	Form	What it is	Period
Oct 31, 202410-Q	10-Q	Quarterly report, Q3 2024 — revenue $11.89B (+8% y/y), net income $1.21B, EPS $0.60	Sep 30, 2024
Oct 31, 20248-K	8-K	Results of operations; Regulation FD disclosure	Oct 31, 2024
Jul 26, 202410-Q	10-Q	Quarterly report, Q2 2024 — revenue $12.20B (+9% y/y), net income $1.68B, EPS $0.83	Jun 30, 2024
Jul 26, 20248-K	8-K	Results of operations; Regulation FD disclosure	Jul 26, 2024
Jun 18, 20248-K	8-K	Directors or officers; compensation	Jun 18, 2024
May 9, 20248-K	8-K	Charter, bylaws or fiscal-year change; Shareholder vote results	May 7, 2024
Apr 25, 202410-Q	10-Q	Quarterly report, Q1 2024 — revenue $11.87B (+5% y/y), net income −$11.91B, EPS −$5.89	Mar 31, 2024
Apr 25, 20248-K	8-K	Results of operations; Regulation FD disclosure	Apr 25, 2024
Apr 22, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Mar 28, 2024ARS	ARS	Annual report to shareholders	Dec 31, 2023
Mar 28, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Mar 28, 2024DEF 14A	DEF 14A	Proxy statement	May 7, 2024
Mar 18, 20248-K	8-K	Directors or officers; compensation	Mar 13, 2024
Mar 18, 2024PRE 14A	PRE 14A	Preliminary proxy statement	May 7, 2024
Mar 18, 20248-K	8-K	Other events	Mar 18, 2024
Feb 22, 20248-K	8-K	Other events	Feb 14, 2024
Feb 15, 20248-K	8-K	Directors or officers; compensation	Feb 13, 2024
Feb 14, 20248-K	8-K	Other events	Feb 14, 2024
Feb 13, 202410-K	10-K	Annual report, FY2023 — revenue $45.01B (−2% y/y), net income $8.03B, EPS $3.86	Dec 31, 2023
Feb 2, 20248-K	8-K	Results of operations; Regulation FD disclosure	Feb 2, 2024
Jan 8, 20248-K	8-K	Regulation FD disclosure	Jan 8, 2024

2023 · 25 filings — 12 × 8-K, 3 × 10-Q, 3 × DEFA14A and 5 other forms

Filed	Form	What it is	Period
Dec 22, 2023DFAN14A	DFAN14A	Proxy statements	—
Dec 22, 2023DFAN14A	DFAN14A	Proxy statements	—
Oct 26, 202310-Q	10-Q	Quarterly report, Q3 2023 — revenue $10.97B (−2% y/y), net income $1.93B, EPS $0.93	Sep 30, 2023
Oct 10, 2023DFAN14A	DFAN14A	Proxy statements	—
Jul 27, 202310-Q	10-Q	Quarterly report, Q2 2023 — revenue $11.23B (−6% y/y), net income $2.07B, EPS $0.99	Jun 30, 2023
Apr 27, 202310-Q	10-Q	Quarterly report, Q1 2023 — revenue $11.34B (−3% y/y), net income $2.26B, EPS $1.07	Mar 31, 2023
Apr 26, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Apr 10, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Mar 23, 2023ARS	ARS	Annual report to shareholders	Dec 31, 2022
Mar 23, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Mar 23, 2023DEF 14A	DEF 14A	Proxy statement	—
Feb 14, 202310-K	10-K	Annual report, FY2022 — revenue $46.16B (−0% y/y), net income $6.33B, EPS $2.95	Dec 31, 2022

13 current reports (8-K) not listed; the year is on EDGAR.

2022 · 23 filings — 15 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms

Filed	Form	What it is	Period
Oct 26, 202210-Q	10-Q	Quarterly report, Q3 2022 — revenue $11.22B (−3% y/y), net income $1.61B, EPS $0.75	Sep 30, 2022
Jul 27, 202210-Q	10-Q	Quarterly report, Q2 2022 — revenue $11.89B (+2% y/y), net income $1.42B, EPS $0.66	Jun 30, 2022
Apr 29, 202210-Q	10-Q	Quarterly report, Q1 2022 — revenue $11.65B (+5% y/y), net income $1.28B, EPS $0.59	Mar 31, 2022
Apr 20, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Apr 5, 2022PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 24, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Mar 24, 2022DEF 14A	DEF 14A	Proxy statement	May 3, 2022
Feb 9, 202210-K	10-K	Annual report, FY2021 — revenue $46.38B (+9% y/y), net income $6.99B, EPS $3.12	Dec 31, 2021

15 current reports (8-K) not listed; the year is on EDGAR.

2021 · 26 filings — 17 × 8-K, 3 × 10-Q, 2 × DEFA14A and 4 other forms

Filed	Form	What it is	Period
Oct 27, 202110-Q	10-Q	Quarterly report, Q3 2021 — revenue $11.62B (+10% y/y), net income $1.55B, EPS $0.69	Sep 30, 2021
Jul 28, 202110-Q	10-Q	Quarterly report, Q2 2021 — revenue $11.70B (+16% y/y), net income $1.05B, EPS $0.47	Jun 30, 2021
Apr 29, 202110-Q	10-Q	Quarterly report, Q1 2021 — revenue $11.07B (+3% y/y), net income $2.02B, EPS $0.89	Mar 31, 2021
Apr 19, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Apr 12, 2021PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 25, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Mar 25, 2021DEF 14A	DEF 14A	Proxy statement	May 4, 2021
Mar 12, 2021PRE 14A	PRE 14A	Preliminary proxy statement	May 4, 2021
Feb 10, 202110-K	10-K	Annual report, FY2020 — revenue $42.52B (+63% y/y), net income −$9.02B, EPS −$3.99	Dec 31, 2020

17 current reports (8-K) not listed; the year is on EDGAR.

2020 · 28 filings — 18 × 8-K, 3 × 10-Q, 3 × DEFA14A and 4 other forms

Filed	Form	What it is	Period
Nov 5, 202010-Q	10-Q	Quarterly report, Q3 2020 — revenue $10.54B (+75% y/y), net income $1.87B, EPS $0.82	Sep 30, 2020
Aug 6, 202010-Q	10-Q	Quarterly report, Q2 2020 — revenue $10.13B (+61% y/y), net income −$85.0M, EPS −$0.04	Jun 30, 2020
May 7, 202010-Q	10-Q	Quarterly report, Q1 2020 — revenue $10.78B (+82% y/y), net income −$775.0M, EPS −$0.34	Mar 31, 2020
Apr 23, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Apr 14, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Apr 6, 2020PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 25, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Mar 25, 2020DEF 14A	DEF 14A	Proxy statement	May 5, 2020
Feb 24, 202010-K	10-K	Annual report, FY2019 — revenue $26.14B (+16% y/y), net income $3.44B, EPS $2.01	Dec 31, 2019

19 current reports (8-K) not listed; the year is on EDGAR.

2019 · 54 filings — 39 × 8-K, 7 × DFAN14A, 3 × 10-Q and 5 other forms

Filed	Form	What it is	Period
Oct 31, 201910-Q	10-Q	Quarterly report, Q3 2019 — revenue $6.01B (+6% y/y), net income $1.35B, EPS $0.83	Sep 30, 2019
Jul 25, 201910-Q	10-Q	Quarterly report, Q2 2019 — revenue $6.27B (+10% y/y), net income $1.43B, EPS $0.87	Jun 30, 2019
Apr 30, 2019DEF 14A	DEF 14A	Proxy statement	May 29, 2019
Apr 25, 201910-Q	10-Q	Quarterly report, Q1 2019 — revenue $5.92B (+14% y/y), net income $1.71B, EPS $1.04	Mar 31, 2019
Mar 29, 2019DFAN14A	DFAN14A	Proxy statements	—
Mar 28, 2019DFAN14A	DFAN14A	Proxy statements	—
Mar 22, 2019DFAN14A	DFAN14A	Proxy statements	—
Mar 19, 2019DFAN14A	DFAN14A	Proxy statements	—
Mar 18, 2019DFAN14A	DFAN14A	Proxy statements	—
Mar 15, 2019DEFC14A	DEFC14A	Proxy statements	—
Mar 6, 2019DFAN14A	DFAN14A	Proxy statements	—
Mar 1, 2019PREC14A	PREC14A	Proxy statements	—
Feb 28, 2019DFAN14A	DFAN14A	Proxy statements	—
Feb 25, 201910-K	10-K	Annual report, FY2018 — revenue $22.56B (+9% y/y), net income $4.92B, EPS $3.01	Dec 31, 2018

40 current reports (8-K) not listed; the year is on EDGAR.

2018 · 22 filings — 13 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms

Filed	Form	What it is	Period
Oct 25, 201810-Q	10-Q	Quarterly report, Q3 2018 — revenue $5.69B (+8% y/y), net income $1.90B, EPS $1.16	Sep 30, 2018
Jul 26, 201810-Q	10-Q	Quarterly report, Q2 2018 — revenue $5.70B (+11% y/y), net income $373.0M, EPS $0.23	Jun 30, 2018
Apr 26, 201810-Q	10-Q	Quarterly report, Q1 2018 — revenue $5.19B (+5% y/y), net income $1.49B, EPS $0.91	Mar 31, 2018
Apr 23, 2018DEFA14A	DEFA14A	Additional proxy materials	—
Mar 27, 2018PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 23, 2018PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 22, 2018DEFA14A	DEFA14A	Additional proxy materials	—
Mar 22, 2018DEF 14A	DEF 14A	Proxy statement	May 1, 2018
Feb 13, 201810-K	10-K	Annual report, FY2017 — revenue $20.78B (+7% y/y), net income $1.01B, EPS $0.61	Dec 31, 2017

13 current reports (8-K) not listed; the year is on EDGAR.

2017 · 19 filings — 12 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms

Filed	Form	What it is	Period
Oct 26, 201710-Q	10-Q	Quarterly report, Q3 2017 — revenue $5.25B (+7% y/y), net income $845.0M, EPS $0.51	Sep 30, 2017
Jul 27, 201710-Q	10-Q	Quarterly report, Q2 2017 — revenue $5.14B (+6% y/y), net income $916.0M, EPS $0.56	Jun 30, 2017
Apr 27, 201710-Q	10-Q	Quarterly report, Q1 2017 — revenue $4.93B (+12% y/y), net income $1.57B, EPS $0.94	Mar 31, 2017
Apr 17, 2017DEFA14A	DEFA14A	Additional proxy materials	—
Mar 23, 2017DEFA14A	DEFA14A	Additional proxy materials	—
Mar 23, 2017DEF 14A	DEF 14A	Proxy statement	May 2, 2017
Feb 21, 201710-K	10-K	Annual report, FY2016 — revenue $19.43B (+17% y/y), net income $4.46B, EPS $2.65	Dec 31, 2016

12 current reports (8-K) not listed; the year is on EDGAR.

2016 · 19 filings — 12 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms

Counted, not listed; the year is on EDGAR.

2015 · 23 filings — 10 × 8-K, 4 × DEFA14A, 3 × 10-Q and 5 other forms

Counted, not listed; the year is on EDGAR.

2014 · 17 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms

Counted, not listed; the year is on EDGAR.

2013 · 21 filings — 13 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms

Counted, not listed; the year is on EDGAR.

2012 · 23 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms

Counted, not listed; the year is on EDGAR.

2011 · 16 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2010 · 19 filings — 10 × 8-K, 3 × 10-Q, 2 × DEFA14A and 4 other forms

Counted, not listed; the year is on EDGAR.

2009 · 22 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2008 · 26 filings — 14 × 8-K, 3 × 10-Q, 3 × DFAN14A and 5 other forms

Counted, not listed; the year is on EDGAR.

2007 · 25 filings — 15 × 8-K, 5 × 8-K/A, 3 × 10-Q and 2 other forms

Counted, not listed; the year is on EDGAR.

2006 · 42 filings — 29 × 8-K, 7 × 8-K/A, 3 × 10-Q and 3 other forms

Counted, not listed; the year is on EDGAR.

2005 · 37 filings — 24 × 8-K, 5 × 8-K/A, 3 × 10-Q and 5 other forms

Counted, not listed; the year is on EDGAR.

2004 · 29 filings — 18 × 8-K, 4 × 10-Q/A, 3 × 10-Q and 4 other forms

Counted, not listed; the year is on EDGAR.

2003 · 19 filings — 8 × 8-K, 4 × 10-Q, 2 × 10-Q/A and 5 other forms

Counted, not listed; the year is on EDGAR.

2002 · 6 filings — 2 × 10-Q, 2 × 8-K, 1 × 10-K405 and 1 other form

Counted, not listed; the year is on EDGAR.

2001 · 13 filings — 6 × 8-K, 3 × 10-Q, 2 × 8-K/A and 2 other forms

Counted, not listed; the year is on EDGAR.

2000 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 1 other form

Counted, not listed; the year is on EDGAR.

1999 · 7 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A and 2 other forms

Counted, not listed; the year is on EDGAR.

1998 · 5 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A

Counted, not listed; the year is on EDGAR.

1997 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A and 1 other form

Counted, not listed; the year is on EDGAR.

1996 · 5 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A

Counted, not listed; the year is on EDGAR.

1995 · 7 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

1994 · 5 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A

Counted, not listed; the year is on EDGAR.

Insider, ownership and other filings#

Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.

2026 · 69 filings — 58 × 4, 3 × 11-K, 3 × 144 and 4 other forms

Filed	Form	What it is	Period
Oct 5, 20264	4	Insider transaction (Form 4)	Oct 2, 2026
Oct 2, 20264	4	Insider transaction (Form 4)	Sep 30, 2026
Oct 2, 20264	4	Insider transaction (Form 4)	Sep 30, 2026
Oct 2, 20264	4	Insider transaction (Form 4)	Sep 30, 2026
Oct 2, 20264	4	Insider transaction (Form 4)	Sep 30, 2026
Oct 2, 20264	4	Insider transaction (Form 4)	Sep 30, 2026
Sep 10, 20264	4	Insider transaction (Form 4)	Sep 9, 2026
Sep 9, 2026144	144	Notice of proposed sale (Form 144)	—
Sep 3, 20264	4	Insider transaction (Form 4)	Sep 1, 2026
Aug 26, 20264	4	Insider transaction (Form 4)	Aug 25, 2026
Aug 25, 2026144	144	Notice of proposed sale (Form 144)	—
Aug 7, 2026SCHEDULE 13G	SCHEDULE 13G	Other filings	—
Aug 4, 20264	4	Insider transaction (Form 4)	Aug 1, 2026
Aug 4, 20264	4	Insider transaction (Form 4)	Aug 1, 2026
Jul 2, 20264	4	Insider transaction (Form 4)	Jun 30, 2026
Jul 2, 20264	4	Insider transaction (Form 4)	Jun 30, 2026
Jul 2, 20264	4	Insider transaction (Form 4)	Jun 30, 2026
Jul 2, 20264	4	Insider transaction (Form 4)	Jun 30, 2026
Jul 2, 20264	4	Insider transaction (Form 4)	Jun 30, 2026
Jun 16, 20264	4	Insider transaction (Form 4)	Jun 15, 2026
Jun 5, 20264	4	Insider transaction (Form 4)	Jun 3, 2026
Jun 5, 202611-K	11-K	Employee plan annual report	Dec 31, 2025
Jun 5, 202611-K	11-K	Employee plan annual report	Dec 31, 2025
Jun 5, 202611-K	11-K	Employee plan annual report	Dec 31, 2025
May 8, 2026S-8	S-8	Employee stock plan registration	—

The newest 25 of 69 shown; the full year is on EDGAR.

2025 · 93 filings — 66 × 4, 5 × SC TO-T/A, 5 × SCHEDULE 13G/A and 13 other forms

Filed	Form	What it is	Period
Nov 12, 2025CERT	CERT	NYSE CERTIFICATION	—
Nov 10, 20258-A12B	8-A12B	Exchange listing registration	—
Nov 7, 2025424B5	424B5	Prospectus supplement	—
Nov 5, 2025FWP	FWP	Free writing prospectus	—
Nov 4, 20254	4	Insider transaction (Form 4)	Nov 3, 2025
Nov 4, 20254	4	Insider transaction (Form 4)	Nov 1, 2025
Nov 4, 20254	4	Insider transaction (Form 4)	Nov 1, 2025
Nov 4, 20254	4	Insider transaction (Form 4)	Nov 1, 2025
Nov 3, 2025424B2	424B2	Prospectus supplement	—
Oct 31, 2025POSASR	POSASR	Registration and prospectus	—
Oct 31, 2025SCHEDULE 13G/A	SCHEDULE 13G/A	Other filings	—
Oct 6, 20254	4	Insider transaction (Form 4)	Oct 2, 2025
Oct 2, 20254	4	Insider transaction (Form 4)	Sep 30, 2025
Oct 2, 20254	4	Insider transaction (Form 4)	Sep 30, 2025
Oct 2, 20254	4	Insider transaction (Form 4)	Sep 30, 2025
Oct 2, 20254	4	Insider transaction (Form 4)	Sep 30, 2025
Oct 2, 20254	4	Insider transaction (Form 4)	Sep 30, 2025
Sep 3, 20254	4	Insider transaction (Form 4)	Sep 2, 2025
Sep 3, 20254	4	Insider transaction (Form 4)	Sep 1, 2025
Sep 2, 2025144	144	Notice of proposed sale (Form 144)	—
Aug 5, 20254	4	Insider transaction (Form 4)	Aug 1, 2025
Aug 5, 20253	3	Initial insider holdings (Form 3)	Aug 1, 2025
Aug 5, 20254	4	Insider transaction (Form 4)	Aug 1, 2025
Aug 5, 20254	4	Insider transaction (Form 4)	Aug 2, 2025
Jul 2, 20254	4	Insider transaction (Form 4)	Jul 1, 2025

The newest 25 of 93 shown; the full year is on EDGAR.

2024 · 87 filings — 62 × 4, 5 × SC 13G/A, 4 × 3 and 11 other forms

Filed	Form	What it is	Period
Dec 13, 2024S-3ASR	S-3ASR	Automatic shelf registration	—
Nov 13, 2024SC 13G/A	SC 13G/A	Passive holder above 5% (Schedule 13G), amended	—
Nov 13, 2024SC 13G/A	SC 13G/A	Passive holder above 5% (Schedule 13G), amended	—
Nov 13, 2024SC 13G/A	SC 13G/A	Passive holder above 5% (Schedule 13G), amended	—
Nov 13, 2024SC 13G	SC 13G	Passive holder above 5% (Schedule 13G)	—
Nov 5, 20244	4	Insider transaction (Form 4)	Nov 4, 2024
Nov 5, 20244	4	Insider transaction (Form 4)	Nov 1, 2024
Nov 5, 20244	4	Insider transaction (Form 4)	Nov 1, 2024
Nov 5, 20244	4	Insider transaction (Form 4)	Nov 1, 2024
Nov 5, 20244	4	Insider transaction (Form 4)	Nov 1, 2024
Nov 4, 2024144	144	Notice of proposed sale (Form 144)	—
Oct 4, 2024SC 13G	SC 13G	Passive holder above 5% (Schedule 13G)	—
Oct 3, 20244	4	Insider transaction (Form 4)	Oct 2, 2024
Oct 2, 20244	4	Insider transaction (Form 4)	Sep 30, 2024
Oct 2, 20244	4	Insider transaction (Form 4)	Sep 30, 2024
Oct 2, 20244	4	Insider transaction (Form 4)	Sep 30, 2024
Oct 2, 20244	4	Insider transaction (Form 4)	Sep 30, 2024
Oct 2, 20244	4	Insider transaction (Form 4)	Sep 30, 2024
Oct 2, 20244	4	Insider transaction (Form 4)	Sep 30, 2024
Aug 5, 20244	4	Insider transaction (Form 4)	Aug 1, 2024
Jul 31, 20244	4	Insider transaction (Form 4)	Jul 29, 2024
Jul 31, 20243/A	3/A	Initial insider holdings (Form 3), amended	Jul 1, 2024
Jul 2, 20244	4	Insider transaction (Form 4)	Jul 1, 2024
Jul 2, 20243	3	Initial insider holdings (Form 3)	Jul 1, 2024
Jul 2, 20244	4	Insider transaction (Form 4)	Jun 30, 2024

The newest 25 of 87 shown; the full year is on EDGAR.

2023 · 91 filings — 74 × 4, 4 × 3, 3 × 11-K and 7 other forms

Counted, not listed; the year is on EDGAR.

2022 · 103 filings — 81 × 4, 4 × 3, 4 × SC TO-T/A and 10 other forms

Counted, not listed; the year is on EDGAR.

2021 · 126 filings — 102 × 4, 5 × SC 13G/A, 3 × 11-K and 11 other forms

Counted, not listed; the year is on EDGAR.

2020 · 162 filings — 123 × 4, 6 × 4/A, 5 × 3 and 17 other forms

Counted, not listed; the year is on EDGAR.

2019 · 124 filings — 86 × 4, 8 × 3, 5 × 4/A and 14 other forms

Counted, not listed; the year is on EDGAR.

2018 · 92 filings — 70 × 4, 6 × 3, 5 × CORRESP and 5 other forms

Counted, not listed; the year is on EDGAR.

2017 · 96 filings — 81 × 4, 3 × 11-K, 3 × 3 and 6 other forms

Counted, not listed; the year is on EDGAR.

2016 · 126 filings — 105 × 4, 5 × CORRESP, 5 × UPLOAD and 5 other forms

Counted, not listed; the year is on EDGAR.

2015 · 124 filings — 97 × 4, 4 × SC 13G/A, 4 × UPLOAD and 12 other forms

Counted, not listed; the year is on EDGAR.

2014 · 122 filings — 104 × 4, 4 × NO ACT, 3 × 11-K and 8 other forms

Counted, not listed; the year is on EDGAR.

2013 · 148 filings — 122 × 4, 5 × CORRESP, 3 × 11-K and 10 other forms

Counted, not listed; the year is on EDGAR.

2012 · 140 filings — 97 × 4, 11 × SC TO-T/A, 6 × SC TO-C and 15 other forms

Counted, not listed; the year is on EDGAR.

2011 · 123 filings — 79 × 4, 28 × 4/A, 4 × CORRESP and 7 other forms

Counted, not listed; the year is on EDGAR.

2010 · 127 filings — 88 × 4, 7 × CORRESP, 7 × SC TO-T/A and 12 other forms

Counted, not listed; the year is on EDGAR.

2009 · 179 filings — 96 × 4, 23 × 4/A, 17 × 425 and 14 other forms

Counted, not listed; the year is on EDGAR.

2008 · 112 filings — 76 × 4, 7 × 4/A, 6 × 3 and 12 other forms

Counted, not listed; the year is on EDGAR.

2007 · 106 filings — 76 × 4, 10 × 4/A, 3 × 11-K and 9 other forms

Counted, not listed; the year is on EDGAR.

2006 · 134 filings — 106 × 4, 5 × 4/A, 4 × NO ACT and 10 other forms

Counted, not listed; the year is on EDGAR.

2005 · 125 filings — 91 × 4, 9 × NO ACT, 7 × 3 and 8 other forms

Counted, not listed; the year is on EDGAR.

2004 · 122 filings — 89 × 4, 6 × 424B3, 6 × NO ACT and 8 other forms

Counted, not listed; the year is on EDGAR.

2003 · 47 filings — 32 × 4, 4 × NO ACT, 3 × 11-K and 5 other forms

Counted, not listed; the year is on EDGAR.

2002 · 14 filings — 4 × 11-K, 3 × NO ACT, 3 × SC 13D/A and 3 other forms

Counted, not listed; the year is on EDGAR.

2001 · 13 filings — 4 × SC TO-T/A, 1 × 3, 1 × 424B3 and 7 other forms

Counted, not listed; the year is on EDGAR.

2000 · 6 filings — 3 × SC 13D/A, 3 × SC 13G/A

Counted, not listed; the year is on EDGAR.

1999 · 1 filing — 1 × SC 13D/A

Counted, not listed; the year is on EDGAR.

1998 · 3 filings — 1 × S-3, 1 × S-8, 1 × SC 13G

Counted, not listed; the year is on EDGAR.

1997 · 4 filings — 3 × SC 13G, 1 × 424B5

Counted, not listed; the year is on EDGAR.

1996 · 8 filings — 3 × SC 13D, 1 × 424B5, 1 × S-4 and 3 other forms

Counted, not listed; the year is on EDGAR.

1995 · 4 filings — 1 × S-3, 1 × S-3/A, 1 × S-8 and 1 other form

Counted, not listed; the year is on EDGAR.

1994 · 4 filings — 3 × 11-K, 1 × S-8

Counted, not listed; the year is on EDGAR.

About this data#

Bristol-Myers Squibb Company (BMY) has 3,482 filings on EDGAR going back to 1994: 36 annual reports, 104 quarterly reports and 392 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 11, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Jul 30, 2026, covered results of operations; regulation fd disclosure. Over the last 13 months insiders sold $2.3M in 3 sales and bought nothing on the open market; 146 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.

Every row is a filing EDGAR lists for the registrants that have been Bristol-Myers Squibb Company, read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.

FAQ#

Where can I read BMY's latest 10-K?: BMY's latest annual report, a 10-K, was filed on Feb 11, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
When did BMY last file an 8-K?: On Jul 30, 2026 it covered results of operations; regulation fd disclosure. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Jul 30, 2026.
Are BMY insiders buying or selling?: Over the last 13 months insiders sold $2.3M in 3 sales and bought nothing on the open market; 146 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Massacesi Cristian (EVP,Chief Med Offr,Head of Dev) sold 6,249 shares on Sep 9, 2026 for $403K. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
How many SEC filings has BMY made?: 3,482 filings are on EDGAR under the registrant records that have been Bristol-Myers Squibb Company, going back to 1994; 2,275 of them are insider ownership forms (Forms 3, 4, 5 and 144).

BMY SEC filings (2026)

What happened, last 12 months#

September 2026

August 2026

July 2026

May 2026

April 2026

March 2026

February 2026

January 2026

November 2025

October 2025

Insider transactions#

Reports and proxy statements#

Insider, ownership and other filings#

About this data#

FAQ#